RAD-140 vs LGD-4033 Explained: Benefits, Differences & Muscle Growth

When comparing RAD-140 vs LGD-4033, the biggest challenge is separating laboratory research and limited human studies from the much broader claims found in bodybuilding communities. People searching for LGD-4033 for sale should recognize that both compounds are investigational SARMs, and evidence from preclinical studies or limited human research does not establish their safety or effectiveness for bodybuilding or physique enhancement.

Both compounds are selective androgen receptor modulators, commonly called SARMs. RAD-140 is also known as Testolone, while LGD-4033 is commonly called Ligandrol. Both were developed as investigational compounds intended to produce anabolic effects through the androgen receptor without being conventional anabolic steroids.

For people researching RAD-140 vs. Ligandrol for muscle growth, an important distinction comes first: neither compound is FDA-approved for recreational bodybuilding or general muscle-building use. The FDA specifically warns that SARMs marketed for bodybuilding are unapproved drugs and has cautioned consumers about potentially serious health concerns associated with these products. People searching for sarms for sale should therefore understand that marketing claims do not establish the safety, quality, or effectiveness of these investigational compounds for physique enhancement.

What Is RAD-140?

RAD-140, or Testolone, is an investigational SARM designed to activate androgen receptors. PubChem identifies Testolone as an investigational selective androgen receptor modulator that has been studied in areas including muscle wasting and cancer research.

The androgen receptor is involved in signaling pathways that influence skeletal muscle, bone and other tissues. The concept behind SARMs is to activate this receptor in a more tissue-selective manner than traditional anabolic-androgenic steroids.

That concept is important, but "selective" does not mean that a compound affects only muscle. RAD-140 has been investigated in preclinical models and in clinical research involving postmenopausal women with hormone-receptor-positive breast cancer. ClinicalTrials.gov lists a completed Phase 1 first-in-human study of RAD-140 involving 20 participants. Importantly, this was a cancer-treatment study rather than a bodybuilding trial.

Preclinical research continues to examine RAD-140's effects on muscle and bone. A 2025 animal study, for example, investigated its effects on muscle hypertrophy and bone mineral density. Animal findings can help explain biological mechanisms, but they cannot establish how RAD-140 will perform in healthy athletes.

What Is LGD-4033?

LGD-4033, also known as Ligandrol, is another nonsteroidal SARM that acts on androgen receptors. Like RAD-140, LGD-4033 was investigated partly because researchers wanted to develop compounds capable of producing anabolic effects while potentially reducing some limitations associated with traditional androgen therapy.

LGD-4033 has been evaluated in controlled human research involving healthy men. One frequently cited placebo-controlled study included 76 men aged 21 to 50 and examined lean body mass, muscle strength, stair-climbing power, hormones and other outcomes over 21 days.

RAD-140 vs LGD-4033: How Do They Work?

Both compounds interact with the androgen receptor (AR). Normally, hormones such as testosterone activate androgen receptors and influence gene expression in tissues including skeletal muscle and bone. SARMs were designed to interact with the same general signaling system while attempting to produce a more selective biological response.

In muscle tissue, androgen-receptor activation can influence pathways involved in muscle protein production and tissue maintenance. This creates the theoretical basis for the muscle-building claims surrounding SARMs.

However, there is a major difference between a plausible mechanism and a proven athletic outcome. A compound can demonstrate anabolic activity in cells or animals without producing the same magnitude of benefit in trained human athletes.

RAD-140 vs LGD-4033 for Muscle Growth

This is where the comparison becomes particularly interesting.

Lean Body Mass

LGD-4033 has direct human evidence showing an increase in lean body mass during a short, controlled study. The published trial found a dose-related increase in lean body mass over 21 days. That finding provides considerably stronger evidence than an online claim that a compound "adds muscle quickly."

RAD-140 also has a biological rationale for increasing muscle mass, and animal research has investigated its anabolic properties. However, the human evidence specifically demonstrating muscle gain in healthy resistance-trained adults is much less developed.

Muscle Hypertrophy

Actual muscle hypertrophy is more difficult to establish than an increase in lean body mass. Lean body mass includes more than contractile skeletal muscle, meaning researchers must be careful when translating changes in body composition into claims about actual muscle growth.

Strength

Strength is another area where online discussions often get ahead of scientific research. People may describe dramatic improvements in pressing, squatting or pulling performance after using SARMs. These reports are anecdotal and can be influenced by training experience, nutrition, body weight, programming and expectations.

The controlled LGD-4033 study examined muscle strength and stair-climbing power, but its short duration was not designed to establish long-term athletic performance. For RAD-140, evidence from animal research should not be converted into a claim that the compound reliably produces superior strength gains in humans.

RAD-140 vs LGD-4033: Which Is Stronger?

The word "stronger" can mean several different things.

It could refer to:

• Greater androgen-receptor activity
• Greater lean-mass change
• Greater strength improvement
• Faster changes in body composition
• Greater biological potency

These are not interchangeable.

A compound can have strong receptor activity without producing proportionally greater muscle growth in humans. Likewise, a short clinical study measuring lean body mass cannot establish which compound produces the greatest long-term hypertrophy in trained athletes.

RAD-140 vs LGD-4033 for Men

Most available human evidence involving LGD-4033 has focused on men, including the controlled 76-person study described above. That provides useful information about biological activity but does not establish an optimal approach for bodybuilding. RAD-140 has also been studied clinically, but its first-in-human research involved patients with hormone-receptor-positive breast cancer rather than healthy male athletes.

RAD-140 vs LGD-4033 for Women

The evidence becomes even thinner when considering women interested in bodybuilding. Human research cannot simply be transferred from men to women because androgen signaling, reproductive hormones and physiological responses differ between sexes.

The RAD-140 Phase 1 clinical study involved postmenopausal women with advanced breast cancer, but that population is fundamentally different from healthy female athletes. Therefore, there is insufficient evidence to determine whether RAD-140 or LGD-4033 is preferable for women seeking muscle growth.

What About Dosage and SARM Cycles?

Searches for RAD-140 vs LGD-4033 dosage and cycle comparisons often lead to bodybuilding protocols posted online. Those protocols should not be confused with validated medical recommendations.

Similarly, the concept of "cycling" comes primarily from bodybuilding culture rather than an established clinical standard. There is no scientifically validated recreational RAD-140 or LGD-4033 cycle that can be described as universally appropriate.

For that reason, this comparison does not provide dosing schedules, cycle lengths, stacking instructions or post-cycle drug protocols.

Final Verdict

The most defensible conclusion from current evidence is that LGD-4033 has clearer human evidence for increasing lean body mass, largely because it has been evaluated in controlled human research. RAD-140 remains an investigational compound with substantial interest based on its androgen-receptor activity and preclinical research. However, there is not enough high-quality evidence in healthy athletes to establish that RAD-140 produces greater muscle growth than LGD-4033. People searching for RAD 140 for sale should be aware that RAD-140 is an investigational compound and that current evidence does not establish its safety or effectiveness for bodybuilding or muscle enhancement.

Neither compound has an approved bodybuilding indication, neither has a scientifically established recreational dosage, and neither should be treated as a proven shortcut to athletic development.

That evidence-based approach is more useful than bodybuilding rankings or marketing claims and it provides a clearer picture of what these compounds can and cannot currently be said to do.